> ## Content Index
> Fetch the complete content index at: https://www.smartseniordaily.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Medicare Selects 15 More Drugs for Price Negotiation — Savings Ahead for Millions
- URL: https://www.smartseniordaily.com/medicare-selects-15-more-drugs-for-price-negotiation-savings-ahead-for-millions/
- Published: 2026-01-29T14:37:50.000Z
- Updated: 2026-01-29T14:37:50.000Z
- Description: You'll have to wait a little bit, but it's better than it was
- Author: Gary P Guthrie
- Tags: Medicare

The Centers for Medicare & Medicaid Services (CMS) just announced that **15 high-cost prescription drugs** used by millions of Medicare beneficiaries have been selected for **price negotiations under Medicare**, with new prices set to take effect in **2028** (yes, you'll have to wait a couple of years).

Between **November 2024 and October 2025**, about **1.8 million people with Medicare Part B or Part D** relied on these medications to treat serious and chronic conditions, including **cancer, diabetes, autoimmune disorders, arthritis, asthma, and mental health conditions**. 

Together, the drugs accounted for roughly **$27 billion in Medicare prescription spending**, or about **6% of total Part B and Part D drug costs** during that period.

This marks the **third round of negotiations** under the Medicare Drug Price Negotiation Program, created to help rein in drug costs that have historically risen faster than inflation — especially for seniors on fixed incomes.

## Drugs Selected for 2028 Price Negotiations

- **Anoro Ellipta**
- **Biktarvy**
- **Botox; Botox Cosmetic**
- **Cimzia**
- **Cosentyx**
- **Entyvio**
- **Erleada**
- **Kisqali**
- **Lenvima**
- **Orencia**
- **Rexulti**
- **Trulicity**
- **Verzenio**
- **Xeljanz; Xeljanz XR**
- **Xolair**

CMS also announced that **Tradjenta**, a diabetes drug, has been selected for **renegotiation**.

## What This Means for Seniors

Negotiated prices won’t appear overnight, but once implemented, they are expected to **lower out-of-pocket costs**, especially for people managing long-term or complex health conditions. CMS has emphasized that negotiations are focused on **widely used, high-spending drugs** where savings can have the greatest impact.

*Smart Senior Daily will continue tracking which medications see the biggest price reductions — and what that means for your monthly pharmacy bill.*